Edition:
United Kingdom

Valneva SE (VLS.PA)

VLS.PA on Paris Stock Exchange

3.09EUR
23 Jul 2019
Change (% chg)

-- (--)
Prev Close
€3.09
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
53,084
52-wk High
€4.19
52-wk Low
€3.01

About

Valneva SE is a France-based company that specializes in the development, manufacture and commercialization of vaccines to protect people from infectious diseases through preventative medicine. The Company's portfolio includes two commercial vaccines for travelers: IXIARO/JESPECT, for the prevention of Japanese Encephalitis, and... (more)

Overall

Beta: 1.21
Market Cap(Mil.): €279.57
Shares Outstanding(Mil.): 90.92
Dividend: --
Yield (%): --

Financials

  VLS.PA Industry Sector
P/E (TTM): 44.52 98.06 34.39
EPS (TTM): 0.07 -- --
ROI: 3.73 7.59 12.67
ROE: 5.69 8.10 17.18

BRIEF-Valneva Announces Mutual Agreement With GSK To End Strategic Alliance Agreement

* VALNEVA ANNOUNCES MUTUAL AGREEMENT WITH GSK TO END STRATEGIC ALLIANCE AGREEMENT; REGAINS CONTROL OF RESEARCH AND DEVELOPMENT

20 Jun 2019

Earnings vs. Estimates